Skip to content

A clinical study to compare the effect of two drugs - patala kshara in tilataila and trikantakadi guggulu in patients with Benign Prostatic Hyperplasia.

Effect of Patala kshara with tilataila and Trikantakadi guggulu in reduction of lower urinary tract symptoms secondary to Benign Prostatic Hyperplasia - A Comparative clinical trial - NIL

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/02/062595
Enrollment
70
Registered
2024-02-13
Start date
Unknown
Completion date
Unknown
Last updated
2024-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N401- Benign prostatic hyperplasia withlower urinary tract symptoms

Interventions

None listed

Sponsors

Dr Subi N H
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: •Patients with LUTS secondary to BPH and diagnosed by Transabdominal Ultrasound. •BPH with IPSS score minimum 5. •Patients who are willing to provide written informed consent

Exclusion criteria

Exclusion criteria: •Known cases of Prostatitis, Carcinoma Prostate and those who have undergone any surgery for Prostate. •Known cases with complications of BPH like acute urinary retention, haematuria, hydronephrosis and renal insufficiency. •Known cases of stricture of urethra, congenital contracture of bladder neck and bladder polyps and diverticula. •BPH patients with severe cardiac disease, uncontrolled diabetes mellitus and immuno-compromised. •Those who are contraindicated for the internal use of kshara.

Design outcomes

Primary

MeasureTime frame
Primary outcome– International Prostate Symptom Score (IPSS) and QOL will be assessed using validated questionnaire to quantify the reduction in LUTS .Timepoint: At baseline, 31st day and 61st day.

Secondary

MeasureTime frame
Change in Post-Void Residual urine volume (PVR) & Prostate Volume (PV) will be assessed using Transabdominal Ultrasound.Timepoint: At baseline & after 60 days

Countries

India

Contacts

Public ContactDr Subi N H

PNNM Ayurveda Medical College, Shornur

harisree.ayur@yahoo.co.in09447071367

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026